Thursday, May 9, 2024at 7:30am to Friday, May 10, 2024 at 4:45pm
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
URLs:
Tickets: https://go.evvnt.com/1875091-2?pid=91
Virtual: https://go.evvnt.com/1875091-3?pid=91
Prices:
Practicing Physician/Industry: USD 1395.00,
Military/Retired/Scientist/VA: USD 1295.00,
PA/Nurse: USD 1195.00,
Resident*/Fellow*: USD 1095.00,
Technologist: USD 995.00
Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don Yoo, MD
On Yahoo, Yelp, SuperPages, AmericanTowns and 25 other directories!
Add your social media links and bio and promote your discounts, menus, events.
Be sure your listing is up on all the key local directories with all your important content (social links and product info).